News | ASTRO | July 14, 2023

New proposed rule continues cuts to Medicare reimbursement; Legislative remedies needed to protect patients’ access to care 

New proposed rule continues cuts to Medicare reimbursement; Legislative remedies needed to protect patients’ access to care

Getty Images


July 14, 2023 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Geraldine M. Jacobson, MD, MBA, MPH, FASTRO, Chair of the ASTRO Board of Directors, in response to the proposed 2024 Medicare Physician Fee Schedule (MPFSreleased today by the Centers for Medicare and Medicaid Services (CMS): 

“Another year brings another round of cuts to radiation therapy services for people with cancer under the proposed Medicare fee schedule. ASTRO is disappointed that CMS once again undervalues the impact of radiation oncology and intends to cut reimbursement by an additional 2% in 2024 for this essential cornerstone of cancer care. Medicare spends less on all radiation therapy services than it does on just three top cancer drugs, although radiation is utilized by twice as many beneficiaries. Despite this outsized value, CMS has cut radiation oncology physician fee schedule payments by over 20% in the last decade – more than nearly all other physician specialties. 

The ongoing cuts to radiation oncology reimbursement, coupled with broader cuts to Medicare services, threaten to decrease patients' ability to receive vital, high-value cancer care close to home by driving practice consolidation and undermining the viability of smaller practices. These cuts also underscore the need for long-term, overarching reimbursement reform that will ensure patients can access the care they need. 

ASTRO, the leading medical society for radiation oncology with 10,000 members who are physicians, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapy, recently introduced Radiation Oncology Case Rates (ROCR), a legislative proposal for radiation oncology payment reform. We look forward to working with our Congressional champions to pass the bipartisan Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) to mitigate the impact of clinical labor cuts.  In addition, we need to advance ROCR to increase patient access to care, improve the quality of cancer treatments, reduce disparities for rural and underserved patients, and lower Medicare and patient costs.” 

For more details about ROCR, read an overview from ASTRO’s health policy leadership. 

For more information: www.astro.org

RELATED CMS CONTENT: 

National Cancer Plan Details Goals and Strategies of Cancer Moonshot Program, Highlights Role of Imaging in Screening and Detection 

US Government Issues Final Rules for Surprise Billing 

CMS Withdraws Guidance on Surprise Billing, Out-of-Network Payment Disputes  

ACR Joins "No Surprises Act" Lawsuit to Protect Patient Care  

Major Medical Associations Ask Federal Court for Summary Judgement in No Surprises Lawsuit  

Radiation Oncologists Applaud Biden-Harris Administration's Renewed Commitment to Cancer Moonshot    

Racial/Ethnic Disparities Persist in Lung Cancer Screening Eligibility    

Primary Lung Cancers Detected by LDCT are at Lower Risk of Brain Metastases    

Physician and Patient Groups Call On CMS to Update Medicare Lung Cancer Screening Coverage    

USPSTF Expands Lung Cancer Screening Eligibility Thresholds     

Low-dose CT for Lung Cancer Screening: Benefit Outweighs Potential Harm    

Physician and Patient Groups Call On CMS to Update Medicare Lung Cancer Screening Coverage  


Related Content

News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
News | Quality Assurance (QA)

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
arrow
News | Radiation Therapy

February 8, 2024 — RaySearch Laboratories AB announced that The Royal Marsden NHS Foundation Trust, a specialist cancer ...

Time February 08, 2024
arrow
Videos | RSNA

At RSNA23, Imaging Technology News (ITN) spoke with Bhvita Jani, principal analyst at Signify Research, about ...

Time February 07, 2024
arrow
News | Interventional Radiology

February 6, 2024 — RenovoRx, Inc., a clinical-stage biopharmaceutical company developing novel precision oncology ...

Time February 06, 2024
arrow
News | Treatment Planning

February 2, 2024 — RaySearch Laboratories announced that the number of radiotherapy centers that have chosen RayStation ...

Time February 02, 2024
arrow
Subscribe Now